Macrophages and CNS remyelination

Veronique E Miron1, Robin J M Franklin

  • 1MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.

Insights

Microglia and macrophages play dual roles in the central nervous system, contributing to injury and repair. Their activation states, M1 and M2, are crucial for remyelination, but this process is impacted by aging.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Regenerative Medicine

Background:

  • Microglia are the primary immune cells in the central nervous system (CNS).
  • Both resident microglia and circulating monocytes contribute to CNS inflammation and repair.
  • Microglia/macrophages have demonstrated critical roles in the CNS regenerative process of remyelination.

Purpose of the Study:

  • To review the roles of microglia, monocytes, and their derived macrophages in creating lesion environments conducive to remyelination.
  • To highlight the specific functions of M1 (cytotoxic) and M2 (regenerative) activation phenotypes.
  • To examine how aging affects the pro-regenerative capacity of the innate immune system in the CNS.

Main Methods:

  • Literature review of studies on microglia, monocytes, and macrophages in CNS injury and repair.
  • Analysis of the functional dichotomy of microglia/macrophage activation states (M1 vs. M2).
  • Examination of the impact of aging on immune cell-mediated remyelination.

Main Results:

  • Microglia and macrophages exhibit distinct activation phenotypes (M1/M2) influencing CNS lesion environments.
  • M2 macrophages are associated with pro-regenerative processes, including remyelination.
  • Aging can alter the balance of these phenotypes, potentially impairing the regenerative capacity of the innate immune system.

Conclusions:

  • Microglia and macrophages are key players in CNS repair, with their activation states dictating outcomes.
  • Understanding M1/M2 phenotypes is crucial for developing strategies to promote remyelination.
  • Age-related changes in the innate immune system present a significant challenge for CNS regeneration.